NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Biotage
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Peptide Synthesis Webinar Series Second Installment - Synthesis of Difficult Peptide Sequences - Biotage announces the second installment in its series of webinars focusing on peptide synthesis. The free events are in part a result of the research collaboration with the Faculty of Life Sciences, University of Copenhagen (STO: BIOT)
Peptide Synthesis Webinar Series Second Installment - Synthesis of Difficult Peptide Sequences

 

NewswireToday - /newswire/ - Uppsala, Sweden, 2010/10/25 - Biotage announces the second installment in its series of webinars focusing on peptide synthesis. The free events are in part a result of the research collaboration with the Faculty of Life Sciences, University of Copenhagen (STO: BIOT).

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced the second installment in its series of webinars focusing on peptide synthesis. The free events are in part a result of the research collaboration with Professor Knud J. Jensen at the Faculty of Life Sciences, University of Copenhagen, in developing new applications on the Biotage Syro Wave™ Parallel Peptide Synthesizer in the field of synthetic peptide and protein chemistry. The collaboration builds on Professor Jensen’s previous research in developing novel chemistries for applications of solid-phase peptide synthesis.

There is no charge for the webinar series which is available for viewing at biotage.com/peptides.

Introduced today is the second installment in the webinar series: Robotic Peptide Synthesizer with Microwave Heating, Synthesis of Difficult Peptide Sequences. Presented at the 31st European Peptide Symposium, Copenhagen, Denmark 2010, by A. Pernille Tofteng, Faculty of Life Sciences, University of Copenhagen

The popular first webinar in the series: Microwave & Parallel Peptide Synthesizer: The Best of Both Worlds was also presented at the 31st European Peptide Symposium in Copenhagen, by Amit Mehrotra - Product Manager, Synthesis and Marketing Manager, Peptide Chemistry.

“We are very excited with the positive response we’ve received from professionals around the world regarding this webinar series.” says Amit Mehrotra “These free webinars are available at biotage.com/peptides, our dedicated resource for professionals. Coupled with our ongoing introduction of new products, our efforts illustrate that Biotage is dedicated to peptide professionals and are without question a leader in this important area.”

The webinar series was announced following the recent introduction of Biotage Resolux™ HPLC columns for peptide purification. Resolux premiered at the ACS Fall 2010 National Meeting & Exposition in Boston, Massachusetts USA and at the 31st European Peptide Symposium in Copenhagen, Denmark.

For further press information at Biotage please contact: Rob Thompson, Director of Marketing Communications, 10430 Harris Oaks Blvd., Suite C, Charlotte, NC USA 28269 T: +1 704 654 4847; F: +1 704 654 4917; E: rob.thompson[.]biotage.com

About Biotage
Biotage (biotage.com) offers solutions, knowledge and experience in the areas of analytical and organic chemistry. The customers include the world’s top pharma and biotech companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, and has offices in the United States, United Kingdom and Japan. Biotage has 245 employees and had sales of SEK 394,1m in 2009. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Biotage

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Peptide Synthesis Webinar Series Second Installment - Synthesis of Difficult Peptide Sequences

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Rob Thompson - Biotage.com 
704-654-4900 product_info[.]biotage.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Biotage securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Biotage / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ipsen Strengthens its Pre-clinical Oncology Pipeline with An Exclusive Worldwide-collaboration with BAKX Therapeutics, Inc. for BKX-001
Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe Finds Frost & Sullivan
Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcome
Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease
Exelixis and Ipsen Announce Cabozantinib in Combination with An Immune Checkpoint Inhibitor Significantly Improved Progression
Ipsen Opts-in to Join Exelixis with Ongoing Development of Cabometyx® for People Living with A Form of Thyroid Cancer
Antibiotic Alternatives Stimulate New Product Development in Global Animal Feed Ingredient Market Finds Frost & Sullivan
Health Tech Company Hologram Sciences Launches Personalized Health & Nutrition Innovation with 0 Million Backing
DSM Acquires Flavor & Fragrance Bio-based Intermediates Business from Amyris
Ipsen Receives Positive CHMP Opinion Recommending Cabometyx® in Combination with Opdivo®
DSM and Industry Partners Launch Coalition to Close the Loop on Dyneema® - The World’s Strongest Fiber™
Pharmactive Earns Acclaim from Frost & Sullivan for Helping People Improve their Cognitive Functions with its Saffron-based Ingredient, Affron®
Tergus Lauded by Frost & Sullivan for its Full-spectrum CRO Services for Therapeutics in Dermatology
Sunquest Lauded by Frost & Sullivan for Driving Efficiency and Compliance with its Differentiated Molecular Laboratory Information Management System
DSM Launches Three Times Faster-acting Form of Vitamin D Supplement in Australia to Support Immune Health

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  BizJobs.com





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)